Status:
UNKNOWN
Impact of Perivascular Tissue on Endothelial Function in Coronary Artery Bypass Grafting
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
St. Olavs Hospital
Conditions:
Myocardial Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The success of coronary artery bypass grafting is reliant on the quality of the grafts used. A new technique for harvesting veins used as grafts has been introduced. The study hypothesis is that veins...
Eligibility Criteria
Inclusion
- Isolated elective, primary CABG requiring cardiopulmonary bypass
- Left ventricular ejection fraction \>35%
- at least one saphenous vein graft required as part of revascularization strategy
Exclusion
- Acute or chronic inflammatory diseases
- Malignancies
- Pregnancy
- Previous cardiac surgery
- Serum creatinine \>120 μmol/L
- Coagulopathy
- Insulin dependent diabetes mellitus
- Smoking during last 6 months
- Leg not suitable for No-touch vein harvesting as judged by the operator.
- Need for nitrates on operation day
- not receiving statins
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01834846
Start Date
May 1 2013
End Date
December 1 2021
Last Update
January 5 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Circulation and Imaging
Trondheim, Sør-Trøndelag, Norway, 7042